Article thumbnail
Location of Repository

Benzylpiperazine: the New Zealand legal perspective.

By Thomas Bassindale

Abstract

In 2005 the New Zealand Government created a new schedule of ‘Restricted Substances’ under the Misuse of Drugs Act (1975). Benzylpiperazine was the first drug to be classified as what became known informally as ‘Class D’. The rationale behind that decision and the subsequent reclassification of benzylpiperazine to Class C, in 2008, is discussed

Publisher: Wiley
Year: 2011
DOI identifier: 10.1002/dta.314
OAI identifier: oai:shura.shu.ac.uk:4495
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://dx.doi.org/10.1002/dta.... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.